However, cancer cells usually acquire ability to escape FAS‐medicated apoptosis by downregulating FAS expression[11] or inhibiting its cell surface localization.[12] In this regard, PIR suppression of FAS expression may confer cancer cells ability to escape from FAS‐dependent immunosurveillance. The gene discussed is FAS; the disease is cancer.